SE385374B - Forfarande for framstellning av 2,6-diamino-9-(beta-d-arabinofuranosyl)purin - Google Patents

Forfarande for framstellning av 2,6-diamino-9-(beta-d-arabinofuranosyl)purin

Info

Publication number
SE385374B
SE385374B SE7015440A SE1544070A SE385374B SE 385374 B SE385374 B SE 385374B SE 7015440 A SE7015440 A SE 7015440A SE 1544070 A SE1544070 A SE 1544070A SE 385374 B SE385374 B SE 385374B
Authority
SE
Sweden
Prior art keywords
arabinofuranosyl
purin
diamino
beta
preparing
Prior art date
Application number
SE7015440A
Other languages
English (en)
Swedish (sv)
Inventor
G B Elion
R A Strelitz
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE385374B publication Critical patent/SE385374B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE7015440A 1969-11-17 1970-11-16 Forfarande for framstellning av 2,6-diamino-9-(beta-d-arabinofuranosyl)purin SE385374B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
SE385374B true SE385374B (sv) 1976-06-28

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7015440A SE385374B (sv) 1969-11-17 1970-11-16 Forfarande for framstellning av 2,6-diamino-9-(beta-d-arabinofuranosyl)purin

Country Status (26)

Country Link
US (1) US3666856A (fr)
JP (1) JPS5429520B1 (fr)
AT (1) AT309696B (fr)
BE (1) BE759011A (fr)
BR (1) BR6915136D0 (fr)
CA (1) CA967564A (fr)
CH (2) CH555833A (fr)
CS (1) CS181701B2 (fr)
DE (1) DE2056327C2 (fr)
DK (1) DK128117B (fr)
ES (2) ES385590A1 (fr)
FI (1) FI54315C (fr)
FR (1) FR2073364B1 (fr)
GB (2) GB1338906A (fr)
HU (1) HU163812B (fr)
IE (1) IE34737B1 (fr)
IL (1) IL35658A (fr)
LU (1) LU62071A1 (fr)
MC (1) MC869A1 (fr)
NL (1) NL171589C (fr)
NO (1) NO128156B (fr)
PL (1) PL81167B1 (fr)
SE (1) SE385374B (fr)
YU (2) YU35033B (fr)
ZA (1) ZA707722B (fr)
ZM (1) ZM12970A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
DE68924319T2 (de) * 1988-03-16 1996-05-15 Scripps Research Inst Als therapeutische mittel verwendbare substituierte adeninderivate.
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
AU2001273212A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070413A (en) * 1962-11-15 1967-06-01 Sankyo Co A process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
ZA707722B (en) 1972-06-28
IE34737B1 (en) 1975-08-06
YU35033B (en) 1980-06-30
YU35034B (en) 1980-06-30
YU280670A (en) 1979-12-31
CS181701B2 (en) 1978-03-31
US3666856A (en) 1972-05-30
ZM12970A1 (en) 1972-07-21
NL7016766A (fr) 1971-05-19
CA967564A (en) 1975-05-13
NL171589C (nl) 1983-04-18
DE2056327C2 (de) 1984-10-11
IL35658A0 (en) 1971-01-28
BR6915136D0 (pt) 1973-04-19
YU201978A (en) 1979-12-31
FI54315B (fi) 1978-07-31
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
LU62071A1 (fr) 1971-08-12
BE759011A (fr) 1971-05-17
JPS5429520B1 (fr) 1979-09-25
CH555833A (de) 1974-11-15
NL171589B (nl) 1982-11-16
GB1338906A (en) 1973-11-28
CH555344A (de) 1974-10-31
PL81167B1 (fr) 1975-08-30
FR2073364B1 (fr) 1974-03-22
HU163812B (fr) 1973-10-27
NO128156B (fr) 1973-10-08
AT309696B (de) 1973-08-27
FR2073364A1 (fr) 1971-10-01
DE2056327A1 (de) 1971-06-03
FI54315C (fi) 1978-11-10
ES385590A1 (es) 1973-10-01
IL35658A (en) 1974-10-22
IE34737L (en) 1971-05-17
MC869A1 (fr) 1971-09-28
DK128117B (da) 1974-03-04

Similar Documents

Publication Publication Date Title
SE385374B (sv) Forfarande for framstellning av 2,6-diamino-9-(beta-d-arabinofuranosyl)purin
TR17663A (tr) Akuemuelatoerlerin,bilhassa kursun akuemuelatoerlerin isitilmasina mahsus usul
DK128854B (da) Analogifremgangsmåde til fremstilling af adenosinderivater.
SE390736B (sv) Forfarande for framstellning av maltos
SE409708B (sv) Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner
IT1043806B (it) Procedimento per preparare cinnamamidi sostituite
SE386449B (sv) Forfarande for framstellning av nya 2-aminoalkylamino-tieno(3,2-d)-pyrimidiner
DK131867B (da) Analogifremgangsmåde til fremstilling af adenosinderivater.
NL165762C (nl) Werkwijze om entpolymeren te bereiden.
DK134176B (da) Fremgangsmåde til fremstilling af furan-3-carboxamidderivater.
NL163798C (nl) Werkwijze om copolymeren te bereiden.
FI51700C (fi) Menetelmä rauhoittavina lääkeaineina käyttökelpoisten 6-fenyyli-4H-s-t riatsolo-(1,5a)(1,4)-bentsodiatsepiinien valmistamiseksi.
DK125089B (da) Analogifremgangsmåde til fremstilling af evomonosidderivater.
DK126944B (da) Analogifremgangsmåde til fremstilling af hexahydrobenzindolderivater.
FI52216C (fi) Menetelmä gamma-piperidinobutyrofenonijohdannaisten valmistamiseksi.
DK128778B (da) Analogifremgangsmåde til fremstilling af bis-2-carboxy-chromonylderivater.
AT330022B (de) Hoher skischuh
FI51496C (fi) Menetelmä vanadiinikarbidin valmistamiseksi.
DK123096B (da) Analogifremgangsmåde til fremstilling af neriifolinderivater.
NL173395C (nl) Werkwijze om alfa-benzylacrylonitrilen te bereiden.
DK124331B (da) Analogifremgangsmåde til fremstilling af 14β-hydroksy-15α-acyloksy-4,20(22)-kardadienolider.
DK125241B (da) Analogifremgangsmåde til fremstilling af substituerede o-anilinophenethylalkoholer.
DK125394B (da) Analogifremgangsmåde til fremstilling af benzofuranderivater.
DK139097B (da) Analogifremgangsmåde til fremstilling af isobutyl-cyclohexenyl-derivater.
DK126991B (da) Analogifremgangsmåde til fremstilling af 1-phenoxy-3-amino-2-propanolderivater.